TITLE

Treating Itch in Psoriasis

AUTHOR(S)
Dawn, Aerlyn; Yosipovitch, Gil
PUB. DATE
June 2006
SOURCE
Dermatology Nursing;Jun2006, Vol. 18 Issue 3, p227
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a study on the effective management and treatment of psoriatic itch. Patients with chronic pruritus often have difficulty sleeping, problems concentrating, lowered sex drive, and depression. The treatments recommended for psoriatic itch are tar products, topical corticosteroids, topical salicylates, agents that alter skin sensation, phototherapy, vitamin D analogs, topical immunomodulators, methotrexate, oral mirtazapine, and biologics.
ACCESSION #
21110278

 

Related Articles

  • tazarotene.  // Royal Society of Medicine: Medicines;2002, p523 

    The article presents information on tazarotene which is chemically a derivative of retinol or vitamin A. This drug can be used to treat mild to moderate plaque psoriasis. Administration is by topical application. It should not be used in pregnancy or breast-feeding. Patients should wash hands...

  • Offer systemic therapy as first-line defense. Rutledge, Barbara J. // Dermatology Times;Sep2005 Supplement 4, Vol. 25, pS16 

    Evaluates the efficacy of alefacept therapy as first-line defense for psoriasis. Impact of psoriasis on the quality of life of the patient; Number of people affected with the disease of the year; Treatment paradigms for psoriasis.

  • New oral psoriasis agents show promise. Jesitus, John // Dermatology Times;Sep2004 Supplement, Vol. 25, pS13 

    Introduces different oral treatment for psoriasis. Side effects of the retinoid, an oral tazarotene; Acquisition of a new oral formulation of the drug BG-12 oral fumarate by Biogen; Discussion on the effects of oral pimecrolimus on psoriatic patients.

  • Easing trepidation about biologies. Kapes, Beth // Dermatology Times;Sep2004 Supplement, Vol. 25, pS27 

    Discusses the benefits offered by biologics for psoriasis treatment. Affirmation of David E. Cohen that the new biologic products offer advantages over existing medications; Presentation of new biologics that are approved for treating moderate to sever psoriasis and psoriatic arthritis;...

  • Study shows leading drugs' effectiveness against psoriasis. Jesitus, John // Dermatology Times;Sep2004 Supplement, Vol. 25, pS34 

    The article discusses the effectiveness of leading drugs against psoriasis. Statement of Craig L. Leonardi, associate dermatologist of St. Louis University in Missouri, on the effectiveness of Biogen's alefacept; Clarifications on the length of effectiveness of some drugs; Discussion on the...

  • new drugs for psoriasis might be lifesavers. Steinmehl, Eric; Martin, Adam // Health (Time Inc. Health);Mar2004, Vol. 18 Issue 2, p68 

    Provides information on biologics, a drug for treating psoriasis. Annual cost of the treatment; Percentage of people with psoriasis who consider committing suicide; Description of psoriasis.

  • Managing psoriasis in pediatric cases. Petrou, Ilya // Dermatology Times;Apr2006, Vol. 27 Issue 4, p38 

    The article discusses several options for treating psoriasis in children. Methotrexate can reduce the incidence of vascular incidence in patients with psoriasis. However, methotrexate increases homocysteine levels, which are already elevated in patients with psoriasis. Elidel cream and Protopic...

  • tacalcitol.  // Royal Society of Medicine: Medicines;2002, p522 

    The article presents information on tacalcitol which is an analogue of vitamin D. This drug is used as a skin treatment for plaque psoriasis. Administration is topical. There may be local irritation including itching, burning, erythema and tingling in the extremities. It should not be used in...

  • Soriatane (Acitretin) Effective in Treating Plaque-Type Psoriasis.  // Dermatology Nursing;Aug2006, Vol. 18 Issue 4, p383 

    The article reports that an oral systemic drug Soriatane (acitretin) manufactured by Connectics Corp. had a long-term efficacy on moderate-to-severe plaque-type psoriasis if taken at lower dosage. The Phase IV clinical study involving 77 adults with psoriasis reveals that taking 25 milligram of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics